dsg4 Antibodies

Santa Cruz Biotechnology delivers a wide array of dsg4 monoclonal antibodies for investigating desmoglein 4 (dsg4) in cellular adhesion and skin integrity. dsg4 Antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Desmoglein 4 is a crucial component of desmosomes, which are structures that provide mechanical strength to tissues by facilitating cell-cell adhesion. Dsg4 plays a significant role in maintaining the integrity of the epidermis and is essential for proper skin function. Research has shown that dsg4 dysregulation is linked to various skin disorders, making it a key focus in dermatology and cell biology investigations. Understanding dsg4's molecular mechanisms and interactions can provide valuable insights into skin development and pathology. Exploring dsg4's function in cellular adhesion may reveal new therapeutic approaches for treating skin conditions. Current research continues to uncover new aspects of dsg4's role in maintaining healthy skin and tissue architecture. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of dsg4's role in human health and disease.